CN112941637A - On-DNA Aldol reaction method - Google Patents
On-DNA Aldol reaction method Download PDFInfo
- Publication number
- CN112941637A CN112941637A CN202011426217.0A CN202011426217A CN112941637A CN 112941637 A CN112941637 A CN 112941637A CN 202011426217 A CN202011426217 A CN 202011426217A CN 112941637 A CN112941637 A CN 112941637A
- Authority
- CN
- China
- Prior art keywords
- dna
- equivalents
- compound
- solution
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 29
- 238000005575 aldol reaction Methods 0.000 title claims abstract description 9
- -1 aldehyde compound Chemical class 0.000 claims abstract description 54
- 150000001875 compounds Chemical class 0.000 claims abstract description 51
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 18
- 239000001257 hydrogen Substances 0.000 claims abstract description 18
- 239000003054 catalyst Substances 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 157
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 92
- 238000006243 chemical reaction Methods 0.000 claims description 81
- 239000000203 mixture Substances 0.000 claims description 41
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 230000015572 biosynthetic process Effects 0.000 claims description 22
- 238000003786 synthesis reaction Methods 0.000 claims description 22
- 125000000217 alkyl group Chemical group 0.000 claims description 15
- 239000007853 buffer solution Substances 0.000 claims description 15
- 125000001424 substituent group Chemical group 0.000 claims description 14
- 125000006618 5- to 10-membered aromatic heterocyclic group Chemical group 0.000 claims description 12
- 239000000126 substance Substances 0.000 claims description 11
- 229910052736 halogen Inorganic materials 0.000 claims description 10
- 150000002367 halogens Chemical class 0.000 claims description 10
- 125000003118 aryl group Chemical group 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 125000003729 nucleotide group Chemical group 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 5
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 4
- 239000002773 nucleotide Substances 0.000 claims description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 4
- 125000005037 alkyl phenyl group Chemical group 0.000 claims description 3
- 125000005059 halophenyl group Chemical group 0.000 claims description 3
- 125000005036 alkoxyphenyl group Chemical group 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- VILAVOFMIJHSJA-UHFFFAOYSA-N dicarbon monoxide Chemical group [C]=C=O VILAVOFMIJHSJA-UHFFFAOYSA-N 0.000 claims description 2
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 2
- BLWYXBNNBYXPPL-YFKPBYRVSA-N methyl (2s)-pyrrolidine-2-carboxylate Chemical compound COC(=O)[C@@H]1CCCN1 BLWYXBNNBYXPPL-YFKPBYRVSA-N 0.000 claims description 2
- 239000000178 monomer Substances 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 150000007530 organic bases Chemical class 0.000 claims description 2
- 230000000379 polymerizing effect Effects 0.000 claims description 2
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 239000008346 aqueous phase Substances 0.000 abstract description 6
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 4
- 230000002194 synthesizing effect Effects 0.000 abstract description 4
- 229910052751 metal Inorganic materials 0.000 abstract description 3
- 239000002184 metal Substances 0.000 abstract description 3
- 239000003960 organic solvent Substances 0.000 abstract description 3
- 108020004414 DNA Proteins 0.000 description 53
- HSJKGGMUJITCBW-UHFFFAOYSA-N 3-hydroxybutanal Chemical compound CC(O)CC=O HSJKGGMUJITCBW-UHFFFAOYSA-N 0.000 description 49
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 32
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 32
- 239000004327 boric acid Substances 0.000 description 32
- 238000012869 ethanol precipitation Methods 0.000 description 30
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 24
- 150000001299 aldehydes Chemical class 0.000 description 24
- 239000000872 buffer Substances 0.000 description 24
- 239000000047 product Substances 0.000 description 22
- 102000004190 Enzymes Human genes 0.000 description 20
- 108090000790 Enzymes Proteins 0.000 description 20
- 239000008367 deionised water Substances 0.000 description 20
- 229910021641 deionized water Inorganic materials 0.000 description 20
- 238000002372 labelling Methods 0.000 description 20
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 20
- 238000012544 monitoring process Methods 0.000 description 20
- 239000002244 precipitate Substances 0.000 description 20
- 239000000463 material Substances 0.000 description 19
- 239000007821 HATU Substances 0.000 description 11
- 239000002253 acid Substances 0.000 description 10
- INVYSLWXPIEDIQ-UHFFFAOYSA-N cyclobutanecarbaldehyde Chemical compound O=CC1CCC1 INVYSLWXPIEDIQ-UHFFFAOYSA-N 0.000 description 10
- 238000003260 vortexing Methods 0.000 description 9
- 150000002576 ketones Chemical class 0.000 description 7
- 150000002611 lead compounds Chemical class 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000012917 library technology Methods 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- 229940125961 compound 24 Drugs 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 238000009509 drug development Methods 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 238000013537 high throughput screening Methods 0.000 description 2
- 125000005647 linker group Chemical group 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical group CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 description 1
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 1
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 1
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 1
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 description 1
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 1
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 description 1
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 1
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 1
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 1
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 1
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229940126657 Compound 17 Drugs 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 description 1
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- KGNDCEVUMONOKF-UGPLYTSKSA-N benzyl n-[(2r)-1-[(2s,4r)-2-[[(2s)-6-amino-1-(1,3-benzoxazol-2-yl)-1,1-dihydroxyhexan-2-yl]carbamoyl]-4-[(4-methylphenyl)methoxy]pyrrolidin-1-yl]-1-oxo-4-phenylbutan-2-yl]carbamate Chemical compound C1=CC(C)=CC=C1CO[C@H]1CN(C(=O)[C@@H](CCC=2C=CC=CC=2)NC(=O)OCC=2C=CC=CC=2)[C@H](C(=O)N[C@@H](CCCCN)C(O)(O)C=2OC3=CC=CC=C3N=2)C1 KGNDCEVUMONOKF-UGPLYTSKSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 238000006757 chemical reactions by type Methods 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 229940125797 compound 12 Drugs 0.000 description 1
- 229940126543 compound 14 Drugs 0.000 description 1
- 229940125758 compound 15 Drugs 0.000 description 1
- 229940126142 compound 16 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229940125810 compound 20 Drugs 0.000 description 1
- 229940126086 compound 21 Drugs 0.000 description 1
- 229940126208 compound 22 Drugs 0.000 description 1
- 229940125833 compound 23 Drugs 0.000 description 1
- 229940125846 compound 25 Drugs 0.000 description 1
- 229940125851 compound 27 Drugs 0.000 description 1
- 229940127204 compound 29 Drugs 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 229940125877 compound 31 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 238000002514 liquid chromatography mass spectrum Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000006357 methylene carbonyl group Chemical group [H]C([H])([*:1])C([*:2])=O 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/08—Liquid phase synthesis, i.e. wherein all library building blocks are in liquid phase or in solution during library creation; Particular methods of cleavage from the liquid support
- C40B50/10—Liquid phase synthesis, i.e. wherein all library building blocks are in liquid phase or in solution during library creation; Particular methods of cleavage from the liquid support involving encoding steps
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B30/00—Methods of screening libraries
- C40B30/10—Methods of screening libraries by measuring physical properties, e.g. mass
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
- C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
Abstract
The invention relates to an On-DNA Aldol reaction method, which takes an On-DNA aldehyde compound and an alpha hydrogen aldehyde group or ketone group compound as raw materials to obtain an On-DNA product in the presence of a catalyst. The method can be carried out in the mixed aqueous phase of an organic solvent and an aqueous phase, is simple to operate, does not introduce a metal reagent, is environment-friendly, and is suitable for synthesizing a DNA coding compound library by using a porous plate.
Description
Technical Field
The invention belongs to the technical field of coding compound libraries, and particularly relates to an On-DNA Aldol reaction method in the construction of a DNA coding compound library.
Background
In drug development, especially new drug development, high-throughput screening for biological targets is one of the main means for rapidly obtaining lead compounds. However, traditional high throughput screening based on single molecules requires long time, large equipment investment, limited number of library compounds (millions), and the building of compound libraries requires decades of accumulation, limiting the efficiency and possibility of discovery of lead compounds. The recent DNA-encoded compound library technologies (WO2005058479, WO2018166532, CN103882532) combine the technologies of combinatorial chemistry and molecular biology, add a DNA tag to each compound on the molecular level, and synthesize up to hundred million levels of compound libraries in a very short time, which is a trend of the next generation compound library screening technology, and begin to be widely applied in the pharmaceutical industry, resulting in many positive effects (Accounts of Chemical Research,2014,47, 1247-.
The DNA coding compound library can rapidly generate a giant compound library through combinatorial chemistry, and can screen out a lead compound with high flux, so that the screening of the lead compound becomes unprecedented rapidness and high efficiency. One of the challenges in constructing libraries of DNA-encoding compounds is the need to synthesize chemically diverse small molecules on DNA in high yields. Because DNA can be kept stable under certain conditions (solvent, pH, temperature and ion concentration), the On-DNA reaction applied to the construction of the DNA coding compound library also needs higher yield. Therefore, the reagent type, reaction type and reaction condition of the chemical reaction (On-DNA reaction for short) carried out On DNA directly influence the richness and selectivity of the DNA coding compound library. Therefore, the development of chemical reactions compatible with DNA is also a long-term research and research direction of the current DNA coding compound library technology, and the application and commercial value of the DNA coding compound library are directly influenced.
The aldol or hydroxyketone compound is an important medicine compound framework or intermediate structure, and the introduction of the aldol or hydroxyketone compound framework into a DNA coding compound library can further expand the diversity of the compound library and is beneficial to improving the probability of screening effective compounds. However, no method for constructing On-DNA aldol or hydroxyketone compounds from On-DNA aldehyde compounds has been reported. Therefore, it is desired to develop a new method for synthesizing On-DNA aldol or hydroxyketone compounds suitable for large-scale multi-well plate operation, increase the diversity of DNA coding compound libraries, and further improve the application value of the DNA coding compound library technology.
Disclosure of Invention
The invention provides an On-DNA Aldol reaction method, which has mild reaction conditions and simple post-treatment, is suitable for the production of a DNA coding compound library and can obviously improve the molecular diversity of the compound library.
The invention provides a method for On-DNA Aldol reaction, which takes an On-DNA aldehyde compound and an alpha hydrogen aldehyde group or ketone group compound as raw materials to obtain an On-DNA product in the presence of a catalyst; wherein the structural formula of the On-DNA aldehyde compound is DNA-R3-CHO, the structural formula of the alpha hydrogen aldehyde group or ketone group compound isThe structural formula of the On-DNA product is shown in the specification
Wherein the DNA in the structural formula comprises a single-stranded or double-stranded nucleotide chain obtained by polymerizing artificially modified and/or unmodified nucleotide monomers, and the nucleotide chain is connected with R through one or more chemical bonds or groups3Connecting; the length of the DNA is 10-200 bases.
Wherein, the DNA and R in the structural formula3Linked by a chemical bond or multiple chemical bonds or groups; when a chemical bond is present, it means DNA and R in the structural formula3Directly connecting; when there are a plurality of chemical bonds or groups, it means DNA and R in the structural formula3Are connected with a plurality of chemical bonds at intervals, for example, DNA and R3Through a methylene group (-CH)2-) are connected, i.e. by twoA plurality of chemical bonds; or DNA and R3The amino group of the DNA is connected with the amino group of the DNA through a carbonyl (-CO-) and is also connected through two chemical bonds; or DNA and R3Through a methylene carbonyl group (-CH)2CO-) is attached to the amino group of the DNA, i.e., by three consecutive chemical bonds.
R1Selected from hydrogen or a group with molecular weight below 1000 directly connected with carbon atom at alpha position of carbonyl;
R2selected from hydrogen or a group having a molecular weight of 1000 or less directly bonded to the carbonyl carbon atom;
R3selected from the group consisting of groups having a molecular weight of 1000 or less directly linked to DNA and an aldehyde carbon atom or being absent;
R4selected from hydrogen or a group with molecular weight below 1000 directly connected with carbon atom at alpha position of carbonyl;
or R1And R4Looping; or R2Are each independently of R1Or R4Looping;
preferably, R is1、R2、R3、R4Each independently selected from alkyl, substituted alkyl, hydroxy, C1~C20Alkoxy, 5-10-membered aryl, substituted 5-10-membered aryl, 5-10-membered aromatic heterocyclic group, substituted 5-10-membered aromatic heterocyclic group; wherein the alkyl is C1~C20Alkyl or C3~C8A cycloalkyl group; the number of substituents of the substituted alkyl group is one or more; the substituents of the substituted alkyl are independently selected from hydroxyl, halogen, carboxyl, nitro and C1~C20Alkoxy, halophenyl, phenyl, alkylphenyl, C1~C20One or more of alkoxyphenyl, 5-10 membered aromatic heterocyclic group, and carboxyl-substituted 5-10 membered aromatic heterocyclic group; the number of the substituent for substituting the 5-to 10-membered aryl is one or more, and the substituent for substituting the 5-to 10-membered aryl is independently selected from hydroxyl, halogen, cyano, nitro, carboxyl and C1~C20Alkoxy radical, C1~C20One or more of alkyl and trifluoromethyl; the number of the substituents for substituting the 5-to 10-membered aromatic heterocyclic group is one or more, and the 5-to 10-membered aromatic heterocyclic group is substitutedThe substituents are independently selected from halogen, cyano, nitro, carboxyl and C1~C20Alkoxy radical, C1~C20One or more of alkyl and trifluoromethyl.
More specifically, R is3Selected from phenyl, substituted phenyl, pyridyl, furyl; the substituent of the substituted phenyl is selected from C1~C6Alkoxy, halogen substituted C1~C6Alkoxy, halogen; said C is1~C6Alkoxy is selected from methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, tert-butoxy, pentoxy, hexoxy.
Another object of the present invention is to provide a method of On-DNA Aldol reaction comprising the steps of: adding 1-50 times of molar equivalent of catalyst into an On-DNA aldehyde compound solution with the molar equivalent of 1 and the molar concentration of 0.5-5mM, then adding 10-1000 times of molar equivalent of alpha hydrogen aldehyde or ketone compound, and reacting for 0.5-24 hours at 10-100 ℃.
Further, the catalyst is proline methyl ester, proline, pyrrolidine or piperidine; preferably, the catalyst is proline.
Further, the reaction is carried out in a solvent, wherein the solvent is a water-containing mixed solvent of any one or more of water, methanol, ethanol, acetonitrile, dimethyl sulfoxide, an inorganic salt buffer solution, an organic acid buffer solution and an organic base buffer solution; preferably, the reaction solvent contains a boric acid buffer.
Furthermore, the pH value of the boric acid buffer solution is 8-10; preferably, the pH is 9.4.
Further, in the reaction method, the molar equivalent of the On-DNA aldehyde-based compound is 1, the molar equivalent of the alpha hydrogen aldehyde-based or ketone-based compound is 20 equivalents, 50 equivalents, 100 equivalents, 200 equivalents, 400 equivalents, 800 equivalents, and the molar equivalent of the catalyst is 2 equivalents, 5 equivalents, 10 equivalents, 20 equivalents, 30 equivalents, 40 equivalents.
Further, the reaction temperature of the reaction is 20 ℃, 30 ℃, 40 ℃, 50 ℃ or 60 ℃.
Further, the reaction time of the reaction is 0.5 hour, 1 hour, 2 hours, 3 hours, 4 hours, 6 hours, or 8 hours.
Furthermore, the feeding sequence of the reaction is that the On-DNA aldehyde group compound is added firstly, then the catalyst is added, and finally the alpha hydrogen aldehyde group or ketone group compound is added.
Further, the above method is used for batch multi-well plate operations.
Further, the above method is used for the synthesis of libraries of DNA-encoding compounds for multi-well plates.
The method can realize the construction of the On-DNA Aldol or hydroxyketone compound in the DNA coding compound library through Aldol reaction and is suitable for various aldehyde and ketone substrates. The method can be carried out in the mixed aqueous phase of an organic solvent and an aqueous phase, is simple to operate, does not introduce a metal reagent, is environment-friendly, and is suitable for synthesizing a DNA coding compound library by using a porous plate.
Definitions of terms used in connection with the present invention: the initial definitions provided herein for a group or term apply to that group or term throughout the specification unless otherwise indicated; for terms not specifically defined herein, the meanings that would be given to them by a person skilled in the art are to be given in light of the disclosure and the context.
"substituted" means that a hydrogen atom in a molecule is replaced by a different atom or molecule.
The minimum and maximum values of the carbon atom content in the hydrocarbon group are indicated by a prefix, e.g. prefix (Ca-C)b) Alkyl means any alkyl group containing from "a" to "b" carbon atoms. Thus, for example, C1~C12The alkyl group is a straight-chain or branched alkyl group having 1 to 12 carbon atoms.
Alkyl means a straight or branched hydrocarbon radical in an alkane molecule, e.g. methyl-CH3ethyl-CH2CH3methylene-CH2-; the alkyl group may also be part of another group, such as C1~C6Alkoxy radical, C1~C6An alkylamino group.
Cycloalkyl refers to a saturated or partially saturated cyclic group having multiple carbon atoms and no ring heteroatoms, and having a single ring or multiple rings (including fused, bridged, and spiro ring systems).
The halogen is fluorine, chlorine, bromine or iodine.
Alkoxy means that the alkyl radical is linked to an oxygen atom to form a substituent, e.g. methoxy is-OCH3。
The halophenyl group means a group in which H on a phenyl group is substituted with halogen.
Alkylphenyl refers to a group formed by substituting H on a phenyl group with an alkyl group.
Aryl means an aromatic monocyclic or multicyclic group consisting of C atoms, free of heteroatoms.
The arylheterocyclyl group is a single cyclic group or a plurality of cyclic groups having aromaticity composed of 5 to 10 atoms such as C, O, S, N.
Obviously, many modifications, substitutions, and variations are possible in light of the above teachings of the invention, without departing from the basic technical spirit of the invention, as defined by the following claims.
The present invention will be described in further detail with reference to the following examples. This should not be understood as limiting the scope of the above-described subject matter of the present invention to the following examples. All the technologies realized based on the above contents of the present invention belong to the scope of the present invention.
Drawings
FIG. 1: LC-MS spectrum and MS spectrum of compound 24 in example 13.
Detailed Description
The technical scheme of the invention is clearly and completely described in the following by combining specific embodiments. It is to be understood that the embodiments described are only a few embodiments of the present invention, and not all embodiments. All other embodiments, which can be obtained by a person skilled in the art without any inventive step based on the embodiments of the present invention, are within the scope of the present invention.
DNA-NH in the present invention2OrIs formed by single-stranded or double-stranded DNA and a linker group and has-NH2DNA constructs for linkers, e.g. DNA-NH of "compound 1" in WO20050584792And (5) structure. Also for example the following DNA structure:
wherein A is adenine, T is thymine, C is cytosine, and G is guanine.
DMA: and (3) dimethylacetamide. HATU: 2- (7-azabenzotriazole) -N, N, N ', N' -tetramethyluronium hexafluorophosphate. DIPEA: n, N-diisopropylethylamine. BBS buffer: a borate buffered solution. DMSO, DMSO: dimethyl sulfoxide (DMSO). The room temperature is 20-30 ℃.
Example 1 Synthesis of On-DNA aldol Compound 3
Dissolving a DNA raw material 1 into a 250mM boric acid buffer solution with the pH value of 9.4 to prepare a 1mM concentration solution (20 mu L, 20nmol), acid aldehyde (1 mu mol, 50 equivalent, 200mM DMA solution), HATU (1 mu mol, 50 equivalent, 400mM DMA solution), DIPEA (1 mu mol, 50 equivalent, 400mM DMA solution) which are respectively placed in a refrigerator with the temperature of-20 ℃ for 5 minutes and then mixed, fully mixing the mixture by vortex oscillation, and then placing the mixture in a refrigerator with the temperature of 4 ℃ for 5 minutes; the mixture was added to the solution of DNA Material 1, mixed well and left overnight at room temperature.
Ethanol precipitation standard procedure: adding 5M sodium chloride solution with the total volume of 10% into the solution, then continuously adding anhydrous ethanol with the total volume of 3 times of the solution, after uniform oscillation, placing the reaction in dry ice for freezing for 2 hours, then centrifuging at 12000rpm for half an hour, and pouring out the supernatant. Directly used for the next reaction.
On-DNA aldehyde compound 2 was dissolved in 250mM boric acid buffer at pH 9.4 to prepare a 1mM concentration solution (10 μ L, 10nmol), proline (100nmol, 10 equiv., 200mM DMSO solution) and cyclobutylformaldehyde (1 μmol, 100 equiv., 200mM DMSO solution) were sequentially added to the solution, and the mixture was mixed well and reacted at room temperature for 2 hours.
After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Dissolving the rest precipitate with deionized water to obtain solution of On-DNA product, quantifying by enzyme labeling instrument OD, and monitoring by LCMS, wherein the theoretical molecular weight of the compound is 5436.1, the actual measured molecular weight is 5435.3, and the conversion rate is 98%.
Example 2 Synthesis of On-DNA aldol Compound 5
DNA material 1 was dissolved in 250mM boric acid buffer at pH 9.4 to prepare a 1mM concentration solution (20 μ L, 20nmol), acid aldehyde (1 μmol, 50 equivalents, 200mM DMA solution), HATU (1 μmol, 50 equivalents, 400mM DMA solution), DIPEA (1 μmol, 50 equivalents, 400mM DMA solution) were placed in a refrigerator at-20 ℃ for 5 minutes, mixed, and the mixture was mixed by vortexing and stored in the refrigerator at 4 ℃ for 5 minutes. The mixture was added to the solution of DNA Material 1, mixed well and left overnight at room temperature. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Directly used for the next reaction.
On-DNA aldehyde compound 4 was dissolved in 250mM boric acid buffer at pH 9.4 to prepare a 1mM concentration solution (10 μ L, 10nmol), proline (100nmol, 10 equiv., 200mM DMSO solution) and cyclobutylformaldehyde (1 μmol, 100 equiv., 200mM DMSO solution) were sequentially added to the solution, and the mixture was mixed well and reacted at room temperature for 2 hours. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Dissolving the rest precipitate with deionized water to obtain solution of On-DNA product, quantifying by enzyme labeling instrument OD, and monitoring by LCMS, wherein the theoretical molecular weight of the compound is 5418.1, the actual measured molecular weight is 5417.9, and the conversion rate is 86%.
Example 3 Synthesis of On-DNA aldol Compound 7
DNA material 1 was dissolved in 250mM boric acid buffer at pH 9.4 to prepare a 1mM concentration solution (20 μ L, 20nmol), acid aldehyde (1 μmol, 50 equivalents, 200mM DMA solution), HATU (1 μmol, 50 equivalents, 400mM DMA solution), DIPEA (1 μmol, 50 equivalents, 400mM DMA solution) were placed in a refrigerator at-20 ℃ for 5 minutes, mixed, and the mixture was mixed by vortexing and stored in the refrigerator at 4 ℃ for 5 minutes. The mixture was added to the solution of DNA Material 1, mixed well and left overnight at room temperature. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Directly used for the next reaction.
The On-DNA aldehyde compound 6 was dissolved in 250mM boric acid buffer solution at pH 9.4 to prepare a 1mM concentration solution (10 μ L, 10nmol), proline (100nmol, 10 equivalents, 200mM DMSO solution) and cyclobutylformaldehyde (1 μmol, 100 equivalents, 200mM DMSO solution) were sequentially added to the solution, and the mixture was mixed well and reacted at room temperature for 2 hours. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Dissolving the rest precipitate with deionized water to obtain solution of On-DNA product, quantifying by enzyme labeling instrument OD, and monitoring by LCMS, wherein the theoretical molecular weight of the compound is 5418.1, the actual measured molecular weight is 5417.5, and the conversion rate is 88%.
Example 4 Synthesis of On-DNA aldol Compound 9
DNA material 1 was dissolved in 250mM boric acid buffer at pH 9.4 to prepare a 1mM concentration solution (20 μ L, 20nmol), acid aldehyde (1 μmol, 50 equivalents, 200mM DMA solution), HATU (1 μmol, 50 equivalents, 400mM DMA solution), DIPEA (1 μmol, 50 equivalents, 400mM DMA solution) were placed in a refrigerator at-20 ℃ for 5 minutes, mixed, and the mixture was mixed by vortexing and stored in the refrigerator at 4 ℃ for 5 minutes. The mixture was added to the solution of DNA Material 1, mixed well and left overnight at room temperature. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Directly used for the next reaction.
The On-DNA aldehyde compound 8 was dissolved in 250mM boric acid buffer solution at pH 9.4 to prepare a 1mM concentration solution (10 μ L, 10nmol), proline (100nmol, 10 equivalents, 200mM DMSO solution) and cyclobutylformaldehyde (1 μmol, 100 equivalents, 200mM DMSO solution) were sequentially added to the solution, and the mixture was mixed well and reacted at room temperature for 2 hours. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Dissolving the rest precipitate with deionized water to obtain solution of On-DNA product, quantifying by enzyme labeling instrument OD, and monitoring by LCMS, wherein the theoretical molecular weight of the compound is 5390.1, the actual measured molecular weight is 5389.5, and the conversion rate is 92%.
Example 5 Synthesis of On-DNA aldol Compound 11
DNA material 1 was dissolved in 250mM boric acid buffer at pH 9.4 to prepare a 1mM concentration solution (20 μ L, 20nmol), acid aldehyde (1 μmol, 50 equivalents, 200mM DMA solution), HATU (1 μmol, 50 equivalents, 400mM DMA solution), DIPEA (1 μmol, 50 equivalents, 400mM DMA solution) were placed in a refrigerator at-20 ℃ for 5 minutes, mixed, and the mixture was mixed by vortexing and stored in the refrigerator at 4 ℃ for 5 minutes. The mixture was added to the solution of DNA Material 1, mixed well and left overnight at room temperature. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Directly used for the next reaction.
The On-DNA aldehyde compound 10 was dissolved in 250mM boric acid buffer solution at pH 9.4 to prepare a 1mM concentration solution (10 μ L, 10nmol), proline (100nmol, 10 equivalents, 200mM DMSO solution) and cyclobutylformaldehyde (1 μmol, 100 equivalents, 200mM DMSO solution) were sequentially added to the solution, and the mixture was mixed well and reacted at room temperature for 2 hours. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Dissolving the rest precipitate with deionized water to obtain solution of On-DNA product, quantifying by enzyme labeling instrument OD, and monitoring by LCMS, wherein the theoretical molecular weight of the compound is 5418.1, the actual measured molecular weight is 5418.0, and the conversion rate is 84%.
Example 6 Synthesis of On-DNA aldol Compound 13
DNA material 1 was dissolved in 250mM boric acid buffer at pH 9.4 to prepare a 1mM concentration solution (20 μ L, 20nmol), acid aldehyde (1 μmol, 50 equivalents, 200mM DMA solution), HATU (1 μmol, 50 equivalents, 400mM DMA solution), DIPEA (1 μmol, 50 equivalents, 400mM DMA solution) were placed in a refrigerator at-20 ℃ for 5 minutes, mixed, and the mixture was mixed by vortexing and stored in the refrigerator at 4 ℃ for 5 minutes. The mixture was added to the solution of DNA Material 1, mixed well and left overnight at room temperature. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Directly used for the next reaction.
The On-DNA aldehyde compound 12 was dissolved in 250mM boric acid buffer solution at pH 9.4 to prepare a 1mM concentration solution (10 μ L, 10nmol), proline (100nmol, 10 equivalents, 200mM DMSO solution) and cyclobutylformaldehyde (1 μmol, 100 equivalents, 200mM DMSO solution) were sequentially added to the solution, and the mixture was mixed well and reacted at room temperature for 2 hours. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Dissolving the rest precipitate with deionized water to obtain solution of On-DNA product, quantifying by enzyme labeling instrument OD, and monitoring by LCMS, wherein the theoretical molecular weight of the compound is 5466.1, the actual measured molecular weight is 5466.0, and the conversion rate is 77%.
Example 7 Synthesis of On-DNA aldol Compound 15
DNA material 1 was dissolved in 250mM boric acid buffer at pH 9.4 to prepare a 1mM concentration solution (20 μ L, 20nmol), and acid aldehyde (1 μmol, 50 equivalents, 200mM DMA solution), HATU (1 μmol, 50 equivalents, 400mM DMA solution), DIPEA (1 μmol, 50 equivalents, 400mM DMA solution) were placed in a refrigerator at-20 ℃ for 5 minutes, mixed, and the mixture was mixed by vortexing and stored in the refrigerator at 4 ℃ for 5 minutes. The mixture was added to the solution of DNA Material 1, mixed well and left overnight at room temperature. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Directly used for the next reaction.
The On-DNA aldehyde compound 14 was dissolved in 250mM boric acid buffer solution at pH 9.4 to prepare a 1mM concentration solution (10 μ L, 10nmol), proline (100nmol, 10 equivalents, 200mM DMSO solution) and cyclobutylformaldehyde (1 μmol, 100 equivalents, 200mM DMSO solution) were sequentially added to the solution, and the mixture was mixed well and reacted at room temperature for 2 hours. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Dissolving the rest precipitate with deionized water to obtain solution of On-DNA product, quantifying by enzyme labeling instrument OD, and monitoring by LCMS, wherein the theoretical molecular weight of the compound is 5436.1, the actual measured molecular weight is 5434.8, and the conversion rate is 73%.
Example 8 Synthesis of On-DNA aldol Compound 17
DNA material 1 was dissolved in 250mM boric acid buffer at pH 9.4 to prepare a 1mM concentration solution (20 μ L, 20nmol), and acid aldehyde (1 μmol, 50 equivalents, 200mM DMA solution), HATU (1 μmol, 50 equivalents, 400mM DMA solution), DIPEA (1 μmol, 50 equivalents, 400mM DMA solution) were placed in a refrigerator at-20 ℃ for 5 minutes, mixed, and the mixture was mixed by vortexing and stored in the refrigerator at 4 ℃ for 5 minutes. The mixture was added to the solution of DNA Material 1, mixed well and left overnight at room temperature. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Directly used for the next reaction.
The On-DNA aldehyde compound 16 was dissolved in 250mM boric acid buffer solution at pH 9.4 to prepare a 1mM concentration solution (10 μ L, 10nmol), proline (100nmol, 10 equivalents, 200mM DMSO solution) and cyclobutylformaldehyde (1 μmol, 100 equivalents, 200mM DMSO solution) were sequentially added to the solution, and the mixture was mixed well and reacted at room temperature for 2 hours. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Dissolving the rest precipitate with deionized water to obtain solution of On-DNA product, quantifying by enzyme labeling instrument OD, and monitoring by LCMS, wherein the theoretical molecular weight of the compound is 5436.1, the actual measured molecular weight is 5434.9, and the conversion rate is 61%.
Example 9 Synthesis of On-DNA aldol Compound 19
DNA material 1 was dissolved in 250mM boric acid buffer at pH 9.4 to prepare a 1mM concentration solution (20 μ L, 20nmol), and acid aldehyde (1 μmol, 50 equivalents, 200mM DMA solution), HATU (1 μmol, 50 equivalents, 400mM DMA solution), DIPEA (1 μmol, 50 equivalents, 400mM DMA solution) were placed in a refrigerator at-20 ℃ for 5 minutes, mixed, and the mixture was mixed by vortexing and stored in the refrigerator at 4 ℃ for 5 minutes. The mixture was added to the solution of DNA Material 1, mixed well and left overnight at room temperature. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Directly used for the next reaction.
The On-DNA aldehyde compound 18 was dissolved in 250mM boric acid buffer at pH 9.4 to prepare a 1mM concentration solution (10 μ L, 10nmol), proline (100nmol, 10 equiv, 200mM DMSO solution) and cyclobutylformaldehyde (1 μmol, 100 equiv, 200mM DMSO solution) were sequentially added to the solution, and the mixture was mixed well and reacted at room temperature for 2 hours. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Dissolving the rest precipitate with deionized water to obtain solution of On-DNA product, quantifying by enzyme labeling instrument OD, and monitoring by LCMS, wherein the theoretical molecular weight of the compound is 5400.1, the actual measured molecular weight is 5399.6, and the conversion rate is 55%.
Example 10 Synthesis of On-DNA aldol Compound 21
DNA material 1 was dissolved in 250mM boric acid buffer at pH 9.4 to prepare a 1mM concentration solution (20 μ L, 20nmol), and acid aldehyde (1 μmol, 50 equivalents, 200mM DMA solution), HATU (1 μmol, 50 equivalents, 400mM DMA solution), DIPEA (1 μmol, 50 equivalents, 400mM DMA solution) were placed in a refrigerator at-20 ℃ for 5 minutes, mixed, and the mixture was mixed by vortexing and stored in the refrigerator at 4 ℃ for 5 minutes. The mixture was added to the solution of DNA Material 1, mixed well and left overnight at room temperature. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Directly used for the next reaction.
The On-DNA aldehyde compound 20 was dissolved in 250mM boric acid buffer solution at pH 9.4 to prepare a 1mM concentration solution (10 μ L, 10nmol), proline (100nmol, 10 equivalents, 200mM DMSO solution) and cyclobutylformaldehyde (1 μmol, 100 equivalents, 200mM DMSO solution) were sequentially added to the solution, and the mixture was mixed well and reacted at room temperature for 2 hours. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Dissolving the rest precipitate with deionized water to obtain solution of On-DNA product, quantifying by enzyme labeling instrument OD, and monitoring by LCMS, wherein the theoretical molecular weight of the compound is 5401.1, the actual measured molecular weight is 5400.5, and the conversion rate is 80%.
Example 11 Synthesis of On-DNA aldol Compound 22
On-DNA aldehyde compound 4 was dissolved in 250mM boric acid buffer at pH 9.4 to prepare a 1mM concentration solution (10 μ L, 10nmol), proline (100nmol, 10 equivalents, 200mM DMSO solution) and aldehyde (1 μmol, 100 equivalents, 200mM DMSO solution) were sequentially added to the solution, and the mixture was mixed well and reacted at room temperature for 2 hours. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Dissolving the rest precipitate with deionized water to obtain solution of On-DNA product, quantifying by enzyme labeling instrument OD, and monitoring by LCMS, wherein the theoretical molecular weight of the compound is 5526.3, the actual measured molecular weight is 5525.6, and the conversion rate is 90%.
Example 12 Synthesis of On-DNA aldol Compound 23
On-DNA aldehyde compound 4 was dissolved in 250mM boric acid buffer at pH 9.4 to prepare a 1mM concentration solution (10 μ L, 10nmol), proline (100nmol, 10 equivalents, 200mM DMSO solution) and ketone (1 μmol, 100 equivalents, 200mM DMSO solution) were sequentially added to the solution, and the mixture was mixed well and reacted at room temperature for 2 hours. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Dissolving the rest precipitate with deionized water to obtain solution of On-DNA product, quantifying by enzyme labeling instrument OD, and monitoring by LCMS, wherein the theoretical molecular weight of the compound is 5484.1, the actual measured molecular weight is 5483.6, and the conversion rate is 89%.
Example 13 Synthesis of On-DNA aldol Compound 24
On-DNA aldehyde compound 4 was dissolved in 250mM boric acid buffer at pH 9.4 to prepare a 1mM concentration solution (10 μ L, 10nmol), proline (100nmol, 10 equivalents, 200mM DMSO solution) and ketone (1 μmol, 100 equivalents, 200mM DMSO solution) were sequentially added to the solution, and the mixture was mixed well and reacted at room temperature for 2 hours. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Dissolving the rest precipitate with deionized water to obtain solution of On-DNA product, quantifying by enzyme labeling instrument OD, and monitoring by LCMS, wherein the theoretical molecular weight of the compound is 5529.2, the actual measured molecular weight is 5528.4, and the conversion rate is 89%.
Example 14 Synthesis of On-DNA aldol Compound 25
On-DNA aldehyde compound 4 was dissolved in 250mM boric acid buffer at pH 9.4 to prepare a 1mM concentration solution (10 μ L, 10nmol), proline (100nmol, 10 equivalents, 200mM DMSO solution) and ketone (1 μmol, 100 equivalents, 200mM DMSO solution) were sequentially added to the solution, and the mixture was mixed well and reacted at room temperature for 2 hours. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Dissolving the rest precipitate with deionized water to obtain solution of On-DNA product, quantifying by enzyme labeling instrument OD, and monitoring by LCMS, wherein the theoretical molecular weight of the compound is 5514.2, the actual measured molecular weight is 5513.6, and the conversion rate is 85%.
Example 15 Synthesis of On-DNA aldol Compound 26
On-DNA aldehyde compound 4 was dissolved in 250mM boric acid buffer at pH 9.4 to prepare a 1mM concentration solution (10 μ L, 10 nmol). Proline (100nmol, 10 equivalents, 200mM DMSO solution) and aldehyde (1. mu. mol, 100 equivalents, 200mM DMSO solution) were added to the solution in this order, mixed well, and reacted at room temperature for 2 hours. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Dissolving the rest precipitate with deionized water to obtain solution of On-DNA product, quantifying by enzyme labeling instrument OD, and monitoring by LCMS, wherein the theoretical molecular weight of the compound is 5494.2, the actual measured molecular weight is 5494.1, and the conversion rate is 84%.
Example 16 Synthesis of On-DNA aldol Compound 27
On-DNA aldehyde compound 4 was dissolved in 250mM boric acid buffer at pH 9.4 to prepare a 1mM concentration solution (10 μ L, 10nmol), proline (100nmol, 10 equivalents, 200mM DMSO solution) and aldehyde (1 μmol, 100 equivalents, 200mM DMSO solution) were sequentially added to the solution, and the mixture was mixed well and reacted at room temperature for 2 hours. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Dissolving the rest precipitate with deionized water to obtain solution of On-DNA product, quantifying by enzyme labeling instrument OD, and monitoring by LCMS, wherein the theoretical molecular weight of the compound is 5436.1, the actual measured molecular weight is 5436.2, and the conversion rate is 76%.
Example 17 Synthesis of On-DNA aldol Compound 28
On-DNA aldehyde compound 4 was dissolved in 250mM boric acid buffer at pH 9.4 to prepare a 1mM concentration solution (10 μ L, 10nmol), proline (100nmol, 10 equivalents, 200mM DMSO solution) and ketone (1 μmol, 100 equivalents, 200mM DMSO solution) were sequentially added to the solution, and the mixture was mixed well and reacted at room temperature for 2 hours. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Dissolving the rest precipitate with deionized water to obtain solution of On-DNA product, quantifying by enzyme labeling instrument OD, and monitoring by LCMS, wherein the theoretical molecular weight of the compound is 5528.2, the actual measured molecular weight is 5528.0, and the conversion rate is 64%.
Example 18 Synthesis of On-DNA aldol Compound 29
On-DNA aldehyde compound 4 was dissolved in 250mM boric acid buffer at pH 9.4 to prepare a 1mM concentration solution (10 μ L, 10nmol), proline (100nmol, 10 equivalents, 200mM DMSO solution) and ketone (1 μmol, 100 equivalents, 200mM DMSO solution) were sequentially added to the solution, and the mixture was mixed well and reacted at room temperature for 2 hours. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Dissolving the rest precipitate with deionized water to obtain solution of On-DNA product, quantifying by enzyme labeling instrument OD, and monitoring by LCMS, wherein the theoretical molecular weight of the compound is 5490.2, the actual measured molecular weight is 5490.2, and the conversion rate is 61%.
Example 19 Synthesis of On-DNA aldol Compound 30
On-DNA aldehyde compound 4 was dissolved in 250mM boric acid buffer at pH 9.4 to prepare a 1mM concentration solution (10 μ L, 10nmol), proline (100nmol, 10 equivalents, 200mM DMSO solution) and aldehyde (1 μmol, 100 equivalents, 200mM DMSO solution) were sequentially added to the solution, and the mixture was mixed well and reacted at room temperature for 2 hours. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Dissolving the rest precipitate with deionized water to obtain solution of On-DNA product, quantifying by enzyme labeling instrument OD, and monitoring by LCMS, wherein the theoretical molecular weight of the compound is 5496.2, the actual measured molecular weight is 5496.2, and the conversion rate is 59%.
Example 20 Synthesis of On-DNA aldol Compound 31
On-DNA aldehyde compound 4 was dissolved in 250mM boric acid buffer at pH 9.4 to prepare a 1mM concentration solution (10 μ L, 10nmol), proline (100nmol, 10 equivalents, 200mM DMSO solution) and aldehyde (1 μmol, 100 equivalents, 200mM DMSO solution) were sequentially added to the solution, and the mixture was mixed well and reacted at room temperature for 2 hours. After the reaction is finished, performing standard operation post-treatment on ethanol precipitation. Dissolving the rest precipitate with deionized water to obtain solution of On-DNA product, quantifying by enzyme labeling instrument OD, and monitoring by LCMS, wherein the theoretical molecular weight of the compound is 5482.2, the actual measured molecular weight is 5482.3, and the conversion rate is 58%.
In conclusion, the On-DNA aldol compound can be obtained by controlling the conditions of solvent, temperature, pH and the like of the reaction and reacting the On-DNA aldehyde compound with the alpha hydrogen aldehyde or ketone compound in the presence of the catalyst. The method can be carried out in the mixed aqueous phase of an organic solvent and an aqueous phase, is simple to operate, does not introduce a metal reagent, is environment-friendly, and is suitable for synthesizing a DNA coding compound library by using a porous plate. The above embodiments and drawings are only preferred embodiments of the present invention and are not intended to limit the scope of the present invention, and any modifications, equivalents, improvements, etc. made within the spirit and principle of the present invention should be included in the scope of the present invention.
Claims (10)
1. A method for On-DNA Aldol reaction is characterized in that: the reaction takes an On-DNA aldehyde compound and an alpha hydrogen aldehyde or ketone compound as raw materials to obtain an On-DNA product in the presence of a catalyst; wherein the structural formula of the On-DNA aldehyde compound is DNA-R3-CHO, the structural formula of the alpha hydrogen aldehyde group or ketone group compound isThe structural formula of the On-DNA product is shown in the specification
Wherein the DNA in the structural formula comprises a single-stranded or double-stranded nucleotide chain obtained by polymerizing artificially modified and/or unmodified nucleotide monomers, and the nucleotide chain is connected with R through one or more chemical bonds or groups3Connecting;
R1selected from hydrogen or a group with molecular weight below 1000 directly connected with carbon atom at alpha position of carbonyl;
R2selected from hydrogen or a group having a molecular weight of 1000 or less directly bonded to the carbonyl carbon atom;
R3selected from the group consisting of groups having a molecular weight of 1000 or less directly linked to DNA and an aldehyde carbon atom or being absent;
R4selected from hydrogen or a group with molecular weight below 1000 directly connected with carbon atom at alpha position of carbonyl;
or R1And R4Looping; or R2Are each independently of R1Or R4Looping.
2. The method of claim 1, wherein: said R1、R2、R3、R4Each independently selected from alkyl, substituted alkyl, hydroxy, C1~C20Alkoxy, 5-10-membered aryl, substituted 5-10-membered aryl, 5-10-membered aromatic heterocyclic group, substituted 5-10-membered aromatic heterocyclic group; wherein the alkyl is C1~C20Alkyl or C3~C8A cycloalkyl group; the number of substituents of the substituted alkyl group is one or more; the substituents of the substituted alkyl are independently selected from hydroxyl, halogen, carboxyl, nitro and C1~C20Alkoxy, halophenyl, phenyl, alkylphenyl, C1~C20One or more of alkoxyphenyl, 5-10 membered aromatic heterocyclic group, and carboxyl-substituted 5-10 membered aromatic heterocyclic group; the number of the substituent for substituting the 5-to 10-membered aryl is one or more, and the substituent for substituting the 5-to 10-membered aryl is independently selected from hydroxyl, halogen, cyano, nitro, carboxyl and C1~C20Alkoxy radical, C1~C20One or more of alkyl and trifluoromethyl; the number of the substituent(s) for substituting the 5-to 10-membered aromatic heterocyclic group is one or more, and the substituent(s) for substituting the 5-to 10-membered aromatic heterocyclic group are independently selected from the group consisting of halogen, cyano, nitro, carboxyl, C1~C20Alkoxy radical, C1~C20One or more of alkyl and trifluoromethyl.
3. The method of claim 1, wherein: the reaction comprises the following reaction steps: adding 1-50 times of molar equivalent of catalyst into an On-DNA aldehyde compound solution with the molar equivalent of 1 and the molar concentration of 0.5-5mM, then adding 10-1000 times of molar equivalent of alpha hydrogen aldehyde or ketone compound, and reacting for 0.5-24 hours at 10-100 ℃.
4. The method of claim 3, wherein: the catalyst is proline, proline methyl ester, tetrahydropyrrole or piperidine.
5. The method of claim 3, wherein: the reaction is carried out in a solvent, and the solvent is one or a mixture of water, methanol, ethanol, acetonitrile, dimethyl sulfoxide, an inorganic salt buffer solution, an organic acid buffer solution and an organic base buffer solution.
6. The method of claim 3, wherein: in the reaction method, the molar equivalent of the On-DNA aldehyde group compound is 1, the molar equivalent of the alpha hydrogen aldehyde group or ketone group compound is 20 equivalents, 50 equivalents, 100 equivalents, 200 equivalents, 400 equivalents and 800 equivalents, and the molar equivalent of the catalyst is 2 equivalents, 5 equivalents, 10 equivalents, 20 equivalents, 30 equivalents and 40 equivalents.
7. The method of claim 3, wherein: the reaction temperature of the reaction is 20 ℃, 30 ℃, 40 ℃, 50 ℃ or 60 ℃.
8. The method of claim 3, wherein: the reaction time of the reaction is 0.5 hour, 1 hour, 2 hours, 3 hours, 4 hours, 6 hours, or 8 hours.
9. The method according to any one of claims 1 to 8, wherein the method is used for a batch multi-well plate operation.
10. The method of any one of claims 1 to 8, wherein the method is used for the synthesis of libraries of DNA-encoding compounds for multi-well plates.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2019112559781 | 2019-12-10 | ||
CN201911255978 | 2019-12-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112941637A true CN112941637A (en) | 2021-06-11 |
Family
ID=76234782
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011426217.0A Pending CN112941637A (en) | 2019-12-10 | 2020-12-10 | On-DNA Aldol reaction method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112941637A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016165621A1 (en) * | 2015-04-14 | 2016-10-20 | 成都先导药物开发有限公司 | Method for solid-phase synthesis of dna-encoded chemical library |
CN109456368A (en) * | 2018-10-11 | 2019-03-12 | 上海药明康德新药开发有限公司 | For DNA encoding compound library building in alkaline buffer and its application |
CN112837757A (en) * | 2019-11-22 | 2021-05-25 | 成都先导药物开发股份有限公司 | On-DNA Aldol reaction method in construction of DNA coding compound library |
-
2020
- 2020-12-10 CN CN202011426217.0A patent/CN112941637A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016165621A1 (en) * | 2015-04-14 | 2016-10-20 | 成都先导药物开发有限公司 | Method for solid-phase synthesis of dna-encoded chemical library |
CN106048736A (en) * | 2015-04-14 | 2016-10-26 | 成都先导药物开发有限公司 | Method for solid-phase synthesis of DNA-coded compound database |
CN109456368A (en) * | 2018-10-11 | 2019-03-12 | 上海药明康德新药开发有限公司 | For DNA encoding compound library building in alkaline buffer and its application |
CN112837757A (en) * | 2019-11-22 | 2021-05-25 | 成都先导药物开发股份有限公司 | On-DNA Aldol reaction method in construction of DNA coding compound library |
Non-Patent Citations (5)
Title |
---|
CHIMNI 等: "Electron deficiency of aldehydes controls the pyrrolidine catalyzed direct cross-aldol reaction of aromatic/heterocyclic aldehydes and ketones in water", 《TETRAHEDRON》 * |
SHU 等: "Solid-Phase Synthesis of β‑Hydroxy Ketones Via DNA-Compatible Organocatalytic Aldol Reactions", 《ACS.COMB.SCI.》 * |
WU 等: "Exploring Aldol Reactions on DNA and Applications to Produce Diverse Structures: An Example of Expanding Chemical Space of DNA-Encoded Compounds by Diversity-Oriented Synthesis", 《CHEM ASIAN J.》 * |
姚其正 主编: "《药物合成反应》", 30 September 2012 * |
郑欣 等: "脯氨酸催化的不对称有机反应", 《化学进展》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110105408B (en) | Synthetic method of On-DNA aryl azide in construction of DNA coding compound library | |
CN112837757A (en) | On-DNA Aldol reaction method in construction of DNA coding compound library | |
CN113089104B (en) | Synthetic method of On-DNA diamine compound ring closure reaction | |
CN112830950B (en) | Method for synthesizing On-DNA (deoxyribonucleic acid) dihydrothiazole/thiazole compound | |
CN113004361B (en) | Method for synthesizing On-DNA pyrazole compound | |
CN113072597A (en) | Method for synthesizing On-DNA carbonyl diazacyclo compound | |
CN112851732B (en) | Method for synthesizing On-DNA 2-carboxyl-3-amino arylthiophene compound | |
CN112920245B (en) | Method for synthesizing On-DNA dihydropyrazole compound | |
CN112941637A (en) | On-DNA Aldol reaction method | |
CN112920246B (en) | Method for synthesizing On-DNA1,4-thiazepine compound | |
CN114075257B (en) | Method for preparing arylamine compound from On-DNA aryl halide | |
CN113563265B (en) | Method for synthesizing On-DNA N, N-monosubstituted indazolone compound | |
CN112920244B (en) | Method for synthesizing On-DNA pyrimidine compound | |
CN112851718A (en) | Method for constructing On-DNA alpha-amino amide compound by aqueous phase Ugi multi-component reaction | |
CN114957348B (en) | Method for synthesizing On-DNA (deoxyribonucleic acid) arylbenzotriazole compound and derivative thereof | |
CN112921406B (en) | Method for synthesizing On-DNA 2-aminopyrimidine compound | |
CN112921405B (en) | Method for synthesizing On-DNA pyrazolo [1,5-a ] pyrimidine compound | |
CN112778380A (en) | Method for synthesizing On-DNA azide | |
CN114957365A (en) | Method for synthesizing On-DNA gamma-aminoketone compound/tetrahydropyrrole compound | |
CN112175021B (en) | Method for synthesizing On-DNA aryl benzyl substituted compound | |
CN112794874A (en) | Synthesis method of On-DNA Petasis reaction | |
CN112831843A (en) | One-pot On-DNA Suzuki reaction method | |
CN114057817B (en) | Method for preparing arylboronic acid from On-DNA aryl halide | |
CN112779606A (en) | Method for On-DNA Mannich reaction | |
CN116411356A (en) | Synthesis method of DNA coding compound ribofuranose derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210611 |
|
RJ01 | Rejection of invention patent application after publication |